Activin and Inhibin

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1IC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT3967385 is a novel USP30 inhibitor that recapitulates genetic loss of USP30 and sets the trigger for PINK1-PARKIN amplification of mitochondrial ubiquitylation.Appearance:SolidBiological Activity:FT3967385 is a novel USP30 inhibitor that

FT3967385 is a novel USP30 inhibitor that recapitulates genetic loss of USP30 and sets the trigger for PINK1-PARKIN amplification of mitochondrial ubiquitylation.Appearance:SolidBiological Activity:FT3967385 is a novel USP30 inhibitor that

FT709 is a potent and selective USP9X inhibitor, an IC 50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemo-sensitization, and circadian rhythms.Form:Solid.

FT709 is a potent and selective USP9X inhibitor, an IC 50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemo-sensitization, and circadian rhythms.Form:Solid.

FT895 is a potent and selective HDAC11 inhibitor with an IC 50 of 3 nMIn VitroFT895 is a highly selective HDAC11 inhibitor showing greater than 1000-fold selectivity against the other 10 members of the HDAC family. MCE has not independently

FT895 is a potent and selective HDAC11 inhibitor with an IC 50 of 3 nMIn VitroFT895 is a highly selective HDAC11 inhibitor showing greater than 1000-fold selectivity against the other 10 members of the HDAC family. MCE has not independently